Taken together, FGFR1 functions as a central regulator of both metabolic and proliferative signaling, and its pharmacological modulation by both agonists and antagonists highlights its broad translational potential in oncology and metabolic disease therapy [15]. This evidence concerns the gene FGFR1 and metabolic disease.